Roundhill GLP-1 & Weight Loss ETF (OZEM) is an ETF managed by Independent / Boutique. Its largest position is ELI LILLY & Co (LLY), representing 16.10% of fund assets.
Roundhill GLP-1 & Weight Loss ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- OZEM
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 22, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
16.10% | $8,280,689.31 | 9,003 |
|
-
NOVO NORDISK A S
|
13.13% | $6,755,899.50 | 183,834 |
|
-
APPLIED MATERIALS INC /DE
|
12.14% | $6,243,130.25 | 6,243,130 |
|
-
PFIZER INC
|
7.56% | $3,886,805.52 | 138,419 |
|
-
Viking Therapeutics, Inc.
|
5.29% | $2,719,335.26 | 83,569 |
|
-
TAISEI CORP.
|
5.11% | $2,625,985.31 | 242,500 |
|
-
APPLIED MATERIALS INC /DE
|
4.67% | $2,404,673.35 | 1,133,000 |
|
-
AMGEN INC
|
3.94% | $2,027,359.70 | 5,762 |
|
-
ROPER TECHNOLOGIES INC
|
3.92% | $2,015,364.57 | 5,146 |
|
-
ASTRAZENECA PLC
|
3.76% | $1,936,503.18 | 9,819 |
|
-
HANMI PHARMACEUTICAL CO LTD
|
3.66% | $1,880,583.03 | 5,593 |
|
-
ZEALAND PHARMA AS
|
3.60% | $1,850,629.88 | 40,685 |
|
-
CHUGAI PHARMACEUTICAL CO LTD.
|
3.45% | $1,775,352.32 | 32,800 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
3.33% | $1,713,715.52 | 2,218 |
|
-
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD.
|
3.26% | $1,674,797.84 | 662,500 |
|
-
CSPC PHARMACEUTICAL GROUP LTD
|
2.93% | $1,506,568.71 | 1,298,000 |
|
-
GUBRA A/S
|
2.42% | $1,243,819.19 | 22,723 |
|
-
Structure Therapeutics Inc.
|
2.38% | $1,223,219.60 | 25,378 |
|
-
APPLIED MATERIALS INC /DE
|
2.27% | $1,169,350.27 | 954,000 |
|
-
MBX Biosciences, Inc.
|
1.99% | $1,022,780.40 | 34,264 |
|
-
GILEAD SCIENCES, INC.
|
1.91% | $981,582.91 | 7,043 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
1.43% | $736,027.11 | 8,463 |
|
-
APPLIED MATERIALS INC /DE
|
1.39% | $713,032.25 | 32,700 |
|
-
Biohaven Ltd.
|
0.87% | $449,175.24 | 53,094 |
|
-
FIRST AMERICAN GOVERNMENT OBLIGATIONS FUND
|
0.75% | $388,152.99 | 388,153 |
|
-
Wave Life Sciences, Inc.
|
0.46% | $237,640.50 | 32,778 |
|
-
Corbus Pharmaceuticals Holdings, Inc.
|
0.40% | $207,810.09 | 22,131 |
Advertisement (320x50)